You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • THU0133 Statistical Assessment across Multiple Early Time Points Validates Biosimilarity of BOW015 To Reference Infliximab in Patients with Active Rheumatoid Arthritis on Stable Methotrexate Doses

Citation Tools

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - anti-TNF therapy
THU0133 Statistical Assessment across Multiple Early Time Points Validates Biosimilarity of BOW015 To Reference Infliximab in Patients with Active Rheumatoid Arthritis on Stable Methotrexate Doses

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Castañeda-Hernández G, Wyand M, Lassen C, et al
THU0133 Statistical Assessment across Multiple Early Time Points Validates Biosimilarity of BOW015 To Reference Infliximab in Patients with Active Rheumatoid Arthritis on Stable Methotrexate Doses
Annals of the Rheumatic Diseases 2016;75:228-229.